企业QQ
官方微信
Precision Antibody™—a wholly owned service division of A&G Pharmaceutical, Inc.— has become recognized as a preeminent contract antibody development company. On average, Precision Antibody can complete a project four to five times faster than our competition, with a success rate exceeding 90%. Since our establishment in 2000, Precision Antibody has developed more than 1,000 novel, customized antibodies for pharmaceutical and biotechnology companies as well as federal and academic research laboratories.